NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-081-2013-4-IN-26 An isolated immunogen IN DIV 202438010632 Pending
NIAID E-001-2017-1-US-01 ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION US CON 18/440,344 12410240 Issued PDF
NCI E-233-2014-0-JP-01 METHODS FOR ISOLATING T CELL RECEPTORS HAVING ANTIGEN SPECIFICITY TO CANCER SPECIFIC MUTATIONS JP DIV 2024-018658 Issued
NCI E-194-2022-0-US-01 COMPOSITIONS AND METHODS FOR THE MANIPULATION OF FUNCTIONAL LONG LIVED PLASMA CELL (LLPC) POPULATIONS AND USE THEREOF FOR TREATMENT AND MODULATION OF DISEASE US 63/552,069 Expired
NIAID E-037-2024-0-US-01 BROADLY NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2 VARIANTS US 63/551,949 Expired
NIAID E-241-2014-0-JP-01 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof JP DIV 2024-016880 Issued
NIDCD E-043-2016-0-CN-08 MICRORNAS AND METHODS OF THEIR USE CN DIV 202410174429.6 Abandoned
NIDCD E-043-2016-0-CN-09 MICRORNAS AND METHODS OF THEIR USE CN DIV 202410174426.2 Abandoned
NCI E-051-2024-0-US-01 MONOCLONAL ANTIBODIES THAT BIND THE JUXTA-MEMBRANE REGION OF MESOTHELIN AND USES THEREOF (RO4 antibody) US 63/550,703 Expired
NCATS E-244-2014-0-US-02 SMALL MOLECULE INHIBITORS OF LACTATE DEHYDROGENASE AND METHODS OF USE THEREOF US CON 18/433,099 Pending
NIAID E-106-2016-0-US-06 PEPTIDE VACCINE FORMULATIONS AND USE THEREOF FOR INDUCING AN IMMUNE
RESPONSE 		US CON 18/432,637 Pending
NEI E-164-2021-0-EP-01 SUPPRESSION OF UVEITIS BY SINGLE DOMAIN ANTIBODY EP National Stage 22838435.0 Pending
NINDS E-117-2021-1-US-01 D3 Dopamine Receptor-Selective Negative Allosteric Modulators. US National Stage 18/294,663 Pending
NCI E-048-2021-0-US-02 HIV-1 VACCINATION AND SAMT-247 MICROBICIDE TO PREVENT HIV-1 INFECTION US National Stage 18/681,019 Pending
NCI E-067-2017-0-HK-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES HK EP 42024086425.6 Pending
NCATS E-198-2016-0-EP-01 NOVEL ALK2 INHIBITORS AND METHODS FOR INHIBITING BMP SIGNALING EP DIV 24155493.0 Pending
NIDCR E-129-2021-0-JP-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction JP National Stage 2024-506727 Pending
NIDCR E-129-2021-0-MY-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction MY National Stage PI2024000751 Pending
NCATS E-116-2016-0-CA-01 CRYSTAL FORMS AND METHODS OF SYNTHESIS OF (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6S)-HYDROXYNORKETAMINE CA DIV 3228060 Pending
NCI E-048-2021-0-CA-01 HIV-1 VACCINATION AND SAMT-247 MICROBICIDE TO PREVENT HIV-1 INFECTION CA National Stage 3228275 Pending
NIDCR E-129-2021-0-BR-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction BR National Stage BR112024002194-7 Pending
NIDCR E-129-2021-0-PH-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction PH National Stage 1-2024-550312 Pending
NIDCR E-129-2021-0-SG-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction SG National Stage 11202400787X Pending
NCATS E-112-2023-0-PC-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF PCT PCT PCT/US2024/014038 Expired
NEI E-015-2019-0-CN-06 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE CN DIV 202410147518.1 Pending
NIDCR E-129-2021-0-MX-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction MX National Stage MX/a/2024/001577 Pending
NCI E-494-2013-0-US-02 METHODS OF PREPARING ANTI-HUMAN PAPILLOMAVIRUS ANTIGEN T CELLS US CON 18/430,031 Pending
NEI E-005-2023-0-PC-01 SYSTEMS AND METHODS FOR DEEP LEARNING TO DETECT RETINAL VASCULITIS ON COLOR FUNDUS PHOTOGRAPHS OF PATIENTS WITH UVEITIS PCT PCT PCT/US2024/013833 Expired
NINDS E-070-2024-0-PC-01 METHODS OF DIAGNOSING AND TREATING MULTIPLE SCLEROSIS BY DETECTING A BIOMARKER IN THE CEREBROSPINAL FLUID PCT PCT PCT/US2024/013658 Expired
NCI E-055-2017-0-US-02 Combination Therapy of Immunotoxin and Checkpoint Inhibitor US CON 18/428,597 Pending
NIDCR E-129-2021-0-US-02 AQP1 GENE THERAPY TO PREVENT RADIATION INDUCED SALIVARY HYPOFUNCTION US National Stage 18/294,048 Pending
NINDS E-070-2024-0-AR-01 Methods of Diagnosing and Treating Multiple Sclerosis AR ORD 20240100235 Pending
NINDS E-070-2024-0-TW-01 Methods of Diagnosing and Treating Multiple Sclerosis TW ORD 113103710 Pending
NIDCR E-129-2021-0-CA-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction CA National Stage 3227584 Pending
NIAID E-135-2025-0-US-02 RESPIRATORY SYNCYTIAL VIRUS VACCINE AND METHODS OF USE US 63/627,541 Expired
NHGRI E-071-2024-0-US-01 SYNTHETIC GBA1 GENES AND AAV VECTORS TO TREAT GAUCHER DISEASE US 63/627,542 Expired
NINDS E-117-2021-1-EP-01 D3 Dopamine Receptor-Selective Negative Allosteric Modulators. EP National Stage 22761746.1 Issued
NIAID E-178-2022-0-PC-01 EPSTEIN-BARR VIRUS GLYCOPROTEIN 42 IMMUNOGENS FOR VACCINATION AND ANTIBODY DISCOVERY PCT PCT PCT/US2024/013311 Expired
NHLBI E-090-2020-0-US-02 NK CELLS OR T CELLS EXPRESSING HEMATOPOIETIC GROWTH FACTOR RECEPTORS AND
METHODS OF USE 		US DIV 18/425,487 Pending
NCATS E-072-2022-1-US-02 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF US National Stage 18/293,109 Pending
NCI E-212-2023-0-US-01 PREDICTING DNA METHYLATION AND TUMOR TYPES FROM HISTOPATHOLOGY US 63/626,277 Expired
NIDCR E-129-2021-0-IL-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction IL National Stage 310485 Pending
NIAID E-050-2018-0-US-08 NIPAH VIRUS IMMUNOGENS AND THEIR USE US DIV 18/424,606 Pending
NCATS E-072-2022-1-JP-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF JP National Stage 2024-504973 Pending
NCATS E-072-2022-1-IL-01 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF IL National Stage 310425 Pending
NCATS E-072-2022-1-BR-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF BR National Stage BR11202400140-2 Pending
NICHD E-004-2024-0-US-01 Enhanced Tumor Reactivity of T cells lacking SIT1, LAX1 or TRAT1 US 63/625,354 Expired
NCI E-175-2016-0-US-02 ANTI-KRAS-G12D T CELL RECEPTORS US CON 18/423,020 12391742 Issued PDF
NCI E-199-2022-0-PC-01 HUMAN PAPILLOMAVIRUS, VARICELLA-ZOSTER VIRUS, AND RABIES VIRUS ANTIGENS AND USES THEREOF IN CANCER IMMUNOTHERAPY PCT PCT PCT/US2024/012976 Expired
NCI E-048-2021-0-AU-01 HIV-1 VACCINATION AND SAMT-247 MICROBICIDE TO PREVENT HIV-1 INFECTION AU National Stage 2022323509 Pending